Defunct Company
Total Trials
4
As Lead Sponsor
As Collaborator
0
Total Enrollment
234
NCT02377895
Allergen Biocube Study Evaluating Efficacy and Safety of Nasapaque Nasal Solution in Adult Subjects With Allergic Rhinitis
Phase: Phase 1/2
Role: Lead Sponsor
Start: Mar 31, 2015
Completion: Jul 31, 2015
NCT04190628
Safety and Tolerability of ABM-1310 in Patients With Advanced Solid Tumors
Phase: Phase 1
Start: Jun 16, 2020
Completion: Apr 5, 2024
NCT05831995
Safety and Effectiveness of ABM-168 in Adults with Advanced Solid Tumors.
Start: Mar 30, 2023
Completion: Jun 30, 2024
NCT06247670
Study of CMP-CPS-001 in Healthy Volunteers
Start: Feb 5, 2024
Completion: Aug 31, 2025